IRE1a: a Conditional Tumor Suppressor

IRE1a:有条件的肿瘤抑制因子

基本信息

  • 批准号:
    10212977
  • 负责人:
  • 金额:
    $ 14.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-08-15 至 2022-01-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT The adaptive response of cells to increased unfolded proteins within the endoplasmic reticulum, or the unfolded protein response (UPR), is a fundamental and conserved cellular survival mechanism. Cancer development is often associated with a range of cytotoxic conditions like hypoxia, nutrient deprivation, and pH changes. These conditions trigger a set of cellular stress response pathways including the ER-stress response. Many aspects of the endoplasmic reticulum (ER)-stress response are adaptive and protect tumor cells from cell death suggesting a crucial role in tumor growth. Much less is known about the role of ER-stress response pathways in early stages of cancer and tumor progression. Activating mutations in Ras proto-oncogenes are among the most common in human cancer. Mouse and human keratinocytes and primary lung epithelial cells respond to expression of oncogenic Ras with proliferation followed by premature senescence. Escape from the senescence response is directly linked to malignant progression. IRE1α is an ER transmembrane protein that has both serine/threonine kinase and endoribonuclease domains. In response to ER-stress IRE1α splices the XBP1 transcript to generate a potent transcription factor that induces expression of genes critical for resolution of ER stress, and in some studies is important in expression of genes regulating the malignant phenotype. The IRE1α nuclease also targets other mRNAs for degradation in a process called RIDD (regulated IRE1α- dependent decay), which can function in the UPR to reduce levels of mRNA’s that encode proteins processed through the ER but also mediates cell death to unremitting ER stress. Both IRE1α and spliced Xbp1 are elevated in cancer, and specific somatic mutations within the IRE1α kinase and RNase domains have been identified in cancers but the function consequences of these are unknown. The major goal of this proposal is to understand how IRE1α expression and RNase outputs modulate cellular responses to oncogenic Ras and promote or suppress Ras-driven cancer. Based on preliminary and submitted data we hypothesize that IRE1α is a conditional tumor suppressor whose actions in cancer depend on the balance between Xbp1 splicing and RIDD. We propose that both ER stress levels and Ras signal strength regulate the balance of IRE1α outputs driving the RNase towards Xbp1 splicing and proliferation or RIDD and senescence. Further we propose a new paradigm of ER stress dependent and independent RIDD targets. Id1 mRNA is a major ER stress independent, Ras dependent RIDD target whose degradation by the IRE1α RNase is essential for oncogene induced senescence. We will use mouse models of KRas-induced NSCLC and epidermal squamous cancer to test the effect of Ire1α or Xbp1 ablation, IRE1α overexpression and specific IRE1α human cancer mutations on cancer development. Together these studies will provide new and impactful information on the role of the IRE1α pathway in epithelial cell carcinogenesis and determine if IRE1α represents a significant target for anticancer therapeutics.
项目总结/文摘

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
TGFβ1 regulates HRas-mediated activation of IRE1α through the PERK-RPAP2 axis in keratinocytes.
The Endoplasmic Reticulum Stress Sensor IRE1α Regulates the UV DNA Repair Response through the Control of Intracellular Calcium Homeostasis.
  • DOI:
    10.1016/j.jid.2021.11.010
  • 发表时间:
    2022-06
  • 期刊:
  • 影响因子:
    6.5
  • 作者:
    Son, Jeongin;Mogre, Saie;Chalmers, Fiona E.;Ibinson, Jack;Worrell, Stephen;Glick, Adam B.
  • 通讯作者:
    Glick, Adam B.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ADAM b GLICK其他文献

ADAM b GLICK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ADAM b GLICK', 18)}}的其他基金

IRE1a: a Conditional Tumor Suppressor
IRE1a:有条件的肿瘤抑制因子
  • 批准号:
    9753162
  • 财政年份:
    2016
  • 资助金额:
    $ 14.62万
  • 项目类别:
IRE1a: a Conditional Tumor Suppressor
IRE1a:有条件的肿瘤抑制因子
  • 批准号:
    9176751
  • 财政年份:
    2016
  • 资助金额:
    $ 14.62万
  • 项目类别:
IRE1a: a Conditional Tumor Suppressor
IRE1a:有条件的肿瘤抑制因子
  • 批准号:
    9326931
  • 财政年份:
    2016
  • 资助金额:
    $ 14.62万
  • 项目类别:
Suppression of Cancer Inflammation with AHR Modulators
用 AHR 调节剂抑制癌症炎症
  • 批准号:
    8529529
  • 财政年份:
    2012
  • 资助金额:
    $ 14.62万
  • 项目类别:
Suppression of Cancer Inflammation with AHR Modulators
用 AHR 调节剂抑制癌症炎症
  • 批准号:
    8384652
  • 财政年份:
    2012
  • 资助金额:
    $ 14.62万
  • 项目类别:
Ninth International Skin Carcinogenesis Conference (ISCC)
第九届国际皮肤癌会议(ISCC)
  • 批准号:
    7912392
  • 财政年份:
    2010
  • 资助金额:
    $ 14.62万
  • 项目类别:
A mouse model of TGFbeta1 and tumor immunosurveillance in Squamous cell cancer
TGFbeta1 和鳞状细胞癌肿瘤免疫监视的小鼠模型
  • 批准号:
    7260505
  • 财政年份:
    2006
  • 资助金额:
    $ 14.62万
  • 项目类别:
A Mouse model of TGFbeta1 and ras oncogene interactions
TGFbeta1 和 ras 癌基因相互作用的小鼠模型
  • 批准号:
    7129481
  • 财政年份:
    2006
  • 资助金额:
    $ 14.62万
  • 项目类别:
A Mouse model of TGFbeta1 and ras oncogene interactions
TGFbeta1 和 ras 癌基因相互作用的小鼠模型
  • 批准号:
    7649555
  • 财政年份:
    2006
  • 资助金额:
    $ 14.62万
  • 项目类别:
A Mouse model of TGFbeta1 and ras oncogene interactions
TGFbeta1 和 ras 癌基因相互作用的小鼠模型
  • 批准号:
    7440319
  • 财政年份:
    2006
  • 资助金额:
    $ 14.62万
  • 项目类别:

相似国自然基金

Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 批准年份:
    2020
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 批准年份:
    2014
  • 资助金额:
    73.0 万元
  • 项目类别:
    面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
  • 批准号:
    81301123
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
  • 批准号:
    81101529
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
  • 批准号:
    39500043
  • 批准年份:
    1995
  • 资助金额:
    9.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
  • 批准号:
    10596657
  • 财政年份:
    2021
  • 资助金额:
    $ 14.62万
  • 项目类别:
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
  • 批准号:
    10417219
  • 财政年份:
    2021
  • 资助金额:
    $ 14.62万
  • 项目类别:
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
  • 批准号:
    441952-2013
  • 财政年份:
    2015
  • 资助金额:
    $ 14.62万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
  • 批准号:
    441952-2013
  • 财政年份:
    2014
  • 资助金额:
    $ 14.62万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Understanding the activation of pro-apoptotic Bcl-2 family proteins for the development of modulators of apoptosis
了解促凋亡 Bcl-2 家族蛋白的激活以开发凋亡调节剂
  • 批准号:
    nhmrc : 1059331
  • 财政年份:
    2014
  • 资助金额:
    $ 14.62万
  • 项目类别:
    Project Grants
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
  • 批准号:
    441952-2013
  • 财政年份:
    2013
  • 资助金额:
    $ 14.62万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Apoptotic Osteocytes Promote Chondrocyte Apoptosis via Soluble Factors
凋亡骨细胞通过可溶性因子促进软骨细胞凋亡
  • 批准号:
    251802
  • 财政年份:
    2012
  • 资助金额:
    $ 14.62万
  • 项目类别:
    Studentship Programs
Defining the mechanism(s) by which the cellular inhibitor of apoptosis protein 2 (cIAP2) contributes to early stage atherosclerosis development by directly promoting the participation of key apoptotic pathways within lesion-associated macrophages
确定凋亡蛋白细胞抑制剂 2 (cIAP2) 通过直接促进病变相关巨噬细胞内关键凋亡途径的参与来促进早期动脉粥样硬化发展的机制
  • 批准号:
    191299
  • 财政年份:
    2009
  • 资助金额:
    $ 14.62万
  • 项目类别:
    Operating Grants
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
  • 批准号:
    8075522
  • 财政年份:
    2009
  • 资助金额:
    $ 14.62万
  • 项目类别:
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
  • 批准号:
    7676912
  • 财政年份:
    2009
  • 资助金额:
    $ 14.62万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了